Literature DB >> 29356629

Immediate Allergic Reactions to Gadolinium-based Contrast Agents: A Systematic Review and Meta-Analysis.

Ashkan Heshmatzadeh Behzadi, Yize Zhao, Zerwa Farooq, Martin R Prince.   

Abstract

Entities:  

Year:  2018        PMID： 29356629     DOI： 10.1148/radiol.2017174037

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  10 in total

Review 1.  Safety issues related to intravenous contrast agent use in magnetic resonance imaging.

Authors:  Skorn Ponrartana; Michael M Moore; Sherwin S Chan; Teresa Victoria; Jonathan R Dillman; Govind B Chavhan
Journal:  Pediatr Radiol       Date:  2021-04-19

2.  Diffusion-weighted MRI for Unenhanced Breast Cancer Screening.

Authors:  Nita Amornsiripanitch; Sebastian Bickelhaupt; Hee Jung Shin; Madeline Dang; Habib Rahbar; Katja Pinker; Savannah C Partridge
Journal:  Radiology       Date:  2019-10-08       Impact factor: 11.105

3.  Gadolinium-based Contrast Agents for Cardiac MRI: Use of Linear and Macrocyclic Agents with Associated Safety Profile from 154 779 European Patients.

Authors:  Johannes Uhlig; Omar Al-Bourini; Rodrigo Salgado; Marco Francone; Rozemarijn Vliegenthart; Jens Bremerich; Joachim Lotz; Matthias Gutberlet
Journal:  Radiol Cardiothorac Imaging       Date:  2020-10-29

Review 4.  Gadolinium-based contrast agents in children.

Authors:  Michael N Rozenfeld; Daniel J Podberesky
Journal:  Pediatr Radiol       Date:  2018-08-04

Review 5.  Magnetic resonance angiography for the primary diagnosis of pulmonary embolism: A review from the international workshop for pulmonary functional imaging.

Authors:  Nanae Tsuchiya; Edwin Jr van Beek; Yoshiharu Ohno; Hiroto Hatabu; Hans-Ulrich Kauczor; Andrew Swift; Jens Vogel-Claussen; Jürgen Biederer; James Wild; Mark O Wielpütz; Mark L Schiebler
Journal:  World J Radiol       Date:  2018-06-28

6.  Acute adverse events in cardiac MR imaging with gadolinium-based contrast agents: results from the European Society of Cardiovascular Radiology (ESCR) MRCT Registry in 72,839 patients.

Authors:  Johannes Uhlig; Christian Lücke; Rozemarijn Vliegenthart; Christian Loewe; Matthias Grothoff; Andreas Schuster; Philipp Lurz; Alexis Jacquier; Marco Francone; Antonia Zapf; Christoph Schülke; Matthias Stefan May; Jens Bremerich; Joachim Lotz; Matthias Gutberlet
Journal:  Eur Radiol       Date:  2019-04-30       Impact factor: 5.315

Review 7.  Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration.

Authors:  Julie Davies; Petra Siebenhandl-Wolff; Francois Tranquart; Paul Jones; Paul Evans
Journal:  Arch Toxicol       Date:  2022-01-08       Impact factor: 5.153

8.  Hypersensitivity to Gadolinium-Based Contrast Media.

Authors:  M Teresa Gracia Bara; Alicia Gallardo-Higueras; Esther M Moreno; Elena Laffond; Francisco J Muñoz Bellido; Cristina Martin; Miriam Sobrino; Eva Macias; Sonia Arriba-Méndez; Rosita Castillo; Ignacio Davila
Journal:  Front Allergy       Date:  2022-03-17

9.  Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI.

Authors:  Kim-Lien Nguyen; Takegawa Yoshida; Nikhita Kathuria-Prakash; Islam H Zaki; Csanad G Varallyay; Scott I Semple; Rola Saouaf; Cynthia K Rigsby; Sokratis Stoumpos; Kevin K Whitehead; Lindsay M Griffin; David Saloner; Michael D Hope; Martin R Prince; Mark A Fogel; Mark L Schiebler; Giles H Roditi; Aleksandra Radjenovic; David E Newby; Edward A Neuwelt; Mustafa R Bashir; Peng Hu; J Paul Finn
Journal:  Radiology       Date:  2019-10-22       Impact factor: 11.105

10.  Immediate reaction to gadolinium based contrast agent with fatal outcome.

Authors:  Ashkan Heshmatzadeh Behzadi; Martin R Prince
Journal:  Radiol Case Rep       Date:  2018-07-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.